Hemolytic anemia secondary to the placement of a portosystemic Stented shunt

作者：Carrillo Esper Raul^*; Carrillo Cortes Ulises; Raul Carrillo Cordova Jorge; Daniel Carrillo Cordova Luis; Alberto Carrillo Cordova Carlos; Maria Carrillo Cordova Dulce

来源：Cirugia y Cirujanos, 2013, 81(2): 143-147.

• portal hypertension
• hemolytic anemia
• crenocite
• transjugular intrahepatic portosystemic stent shunt

Introduction: portal hypertension and variceal hemorrhage are common complications of hepatic cirrhosis, both associated with a high morbimortality. Portal system decompression by the placement of a transjugular intrahepatic portosystemic stented shunt, can reduce portal venus pressure and is effective controling complications of portal hypertension, like variceal hemorrhage and ascitis. The aim of this document is to describe a case of hemolytic anemia secondary to the placement of a transjugular intrahepatic portosystemic stented shunt. %26lt;br%26gt;Clinical case: patient with portal hypertension secondary to liver cirrosis which was placed transjugular intrahepatic portosystemic stented shunt for recurrent variceal hemorrhage. After the procedure, hemoglobin decreased 2 g/dL, associated with reticulocitosis, hipohaptoglobinemia, elevated lactic dehydrogenase and indirect hyperbilirrubinemia with negative Coombs test. The peripheral blood smear showed abnormal erythrocytes, with the prevalence of schistocytes. The final diagnosis was hemolytic anemia secondary to transjugular intrahepatic portosystemic stented shunt. %26lt;br%26gt;Conclusions: the hemolytic anemia secondary to Transjugular Intrahepatic Portosystemic Stented Shunt is a rare complication. Usually, it has a benign prognosis, and it%26apos;s self-limited once the stent is endothelialized.

• 出版日期2013-4